Welcome to Kapvay
Kapvay (clonidine hydrochloride) extended-release tablets are indicated for the treatment of attention deficit/hyperactivity disorder (ADHD). When combined with a stimulant medication, Kapvay may help ADHD patients as part of a comprehensive ADHD treatment plan.
If your child is not getting the symptom relief the doctor had hoped for, adding Kapvay may help.
Learn more >>
|
Understanding ADHD
ADHD is the most commonly diagnosed childhood behavioral disorder. As of 2007, approximately 5.4 million children and adolescents have been diagnosed with ADHD.
Children with ADHD experience periods of not paying attention, overactivity, being impulsive, or a combination of these symptoms. In order for these symptoms to be diagnosed as ADHD, they must be out of the normal range for a child’s age and development.
Learn more >>
|
Results
In clinical trials, most children and adolescents showed improvement in symptoms at Week 5.
After your child starts taking Kapvay, it may take a while before you start noticing a difference in behavior. In order to meet your child’s individual needs, your child’s doctor must adjust the dose of Kapvay during treatment.
Learn more >>
|